TScan Therapeutics (TCRX) Invested Capital (2022 - 2026)
TScan Therapeutics (TCRX) recorded Invested Capital of $70.98 million in Q3 2026, down 59.8% from $176.44 million a year earlier and down 30.3% from the prior quarter.
TScan Therapeutics (TCRX) Invested Capital (2022 - 2026) Analysis & Trends
For FY2025, TScan Therapeutics reported Invested Capital of $155.66 million, down 43.0% from FY2024.
- Annual Invested Capital has a three-year compound annual growth rate of 6.5% (FY2022 to FY2025).
- Across earlier years, Invested Capital came in at $273.04 million in FY2024 (+50.9%), $180.91 million in FY2023 (+40.5%) and $128.72 million in FY2022.
- The Q3 2026 figure is the lowest quarterly Invested Capital in data going back to Q3 2022.
- On a year-over-year basis, Invested Capital has declined for six consecutive quarters, with an average decline of 18.8% over the last eight quarters.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 58.2% in Q1 2025, against a decline of 59.8% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $101.8 million (Q2 2026), $129.58 million (Q1 2026) and $155.66 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 1.14 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 89.77 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 126.18 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 76.32 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 98.72 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | -7.28 Bn |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | 70.98 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 70.98 Mn |
| Jun 30, 2026 | 101.80 Mn |
| Mar 31, 2026 | 129.58 Mn |
| Dec 31, 2025 | 155.66 Mn |
| Sep 30, 2025 | 176.44 Mn |
| Jun 30, 2025 | 209.01 Mn |
| Mar 31, 2025 | 242.38 Mn |
| Dec 31, 2024 | 273.04 Mn |
| Sep 30, 2024 | 259.73 Mn |
| Jun 30, 2024 | 285.67 Mn |
| Mar 31, 2024 | 153.21 Mn |
| Dec 31, 2023 | 180.91 Mn |
| Sep 30, 2023 | 198.91 Mn |
| Jun 30, 2023 | 220.33 Mn |
| Mar 31, 2023 | 107.52 Mn |
| Dec 31, 2022 | 128.72 Mn |
| Sep 30, 2022 | 145.73 Mn |
TScan Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();